Stay updated on Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.

Latest updates to the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page
- Check6 days agoChange DetectedRecruitment status updated to Recruiting with new contacts added: Rebecca Brooks; Principal Investigator Joan Tymon-Rosario; and investigators Prafull Ghatage and Wei-Yu Chen (cwycwy600222@gmail.com). Removed Not yet Recruiting listings for Steven Bisch and Yin-Hsun Feng (yinhsun.feng@gmail.com).SummaryDifference0.3%

- Check14 days agoChange DetectedThe Study Details page now lists a broad set of recruitment sites across the US, Canada, Australia, and Europe (e.g., Alabama, Athens, Elm Park, Gipuzkoa, Ankara), replacing the previous locations list.SummaryDifference0.8%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedAdded a note that publications are auto-filled from PubMed and updated the revision to v3.3.2. Removed the older PubMed-origin publications description that referenced revision v3.2.0.SummaryDifference0.0%

- Check49 days agoChange DetectedStudy Locations updated: added 'Tainan, Taiwan, 71004' and removed 'Tainan City, Taiwan, 71004' from the locations list.SummaryDifference0.1%

- Check64 days agoChange DetectedNo additions or deletions detected; the Study Details page content remains unchanged.SummaryDifference0.1%

- Check71 days agoChange DetectedPublications section updated: added Secord et al., Molecular Characterization and Clinical Implications of Endometrial Cancer (Obstet Gynecol, 2025; 146(5):660-671; Epub 2025 Sep 18), and removed the previous 'Online ahead of print' listing for the same article. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.